查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553553

覆膜支架市场规模、份额、趋势分析报告：按产品、最终用途、地区、细分市场预测，2024-2030 年

Covered Stent Market Size, Share & Trends Analysis Report By Product (Vascular Stent, Non-vascular Stent), By End Use (Hospitals, Ambulatory Care Centers (ACS), Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

覆膜支架市场规模及趋势：

2023年全球覆膜支架市场规模预估为11.3亿美元，预估2024年至2030年复合年增长率为4.1%。

该市场的成长是由血管疾病盛行率的增加、覆膜支架技术的进步、认识和诊断的提高以及应用和适应症范围的扩大所推动的。 2024年4月，美国心臟协会宣布，全球下肢周边动脉疾病（PAD）盛行率高达116至2.3亿人，报告指出这是推动支架需求增加的主要因素。这种高盛行率凸显了对有效血管介入的迫切需求，并将覆膜支架作为管理 PAD 和改善全球患者照护的重要解决方案。

覆膜支架的技术进步正在推动市场成长。 MDPI 2023 年 2 月的一篇报导强调，覆膜支架现在采用聚四氟乙烯 (PTFE) 等先进的生物相容性聚合物设计。这些材料可作为组织浸润的屏障，大大降低了血管再阻塞的风险。此外，它在隔离暴露的发炎表面方面可能特别有效，并可能有助于抑制新内膜增生的发展。

此外，到 2023 年 11 月，3D 列印技术将彻底改变根据每位患者独特的解剖结构量身定制的个人化覆膜支架的製作方法。这种方法可以製造具有客製化尺寸和机械性能的支架，从而提高其性能和在脉管系统中的整合。此外，最新一代的覆膜支架还具有药物释放型功能，可局部输送抗增生药物，进一步降低再血管再阻塞的风险。正在进行的研究正在调查多种药物的顺序释放，以优化癒合过程并最大限度地减少併发症。

覆膜支架的卓越功效是市场成长的主要动力。 Elsevier Ltd. 于 2024 年 4 月发表的一篇论文强调了覆膜支架在治疗慢性肠系膜缺血方面相对于裸金属支架的优越性。在荷兰六个中心进行的一项研究发现，覆膜支架的长期通畅率明显更高，81% 的覆膜支架在 24 个月内实现了初步通畅，而裸金属支架只有 49% 保持其存在。这些性能改进支持了人们对覆膜支架日益增长的偏好，并推动了它们在血管内手术中的采用。

提高意识和诊断是推动市场成长的关键因素。根据耶鲁大学医学院 2023 年 9 月发表的一篇论文，9 月被指定为全国周边动脉疾病(PAD) 宣传月。该倡议旨在透过教育人们了解週边动脉疾病的危险因子、症状和早期诊断的重要性，提高大众对週边动脉疾病的认识。在整个月中，各种组织将提供支持，提供教育材料，并鼓励高风险族群接受血管筛检。主要目的是强调早期发现和治疗的重要性，以预防与 PAD 相关的严重併发症。

此外，2021 年 3 月进行的一项国际调查评估了各国对 PAD 的认知水平，结果显示 57% 的参与者不了解 PAD，凸显了知识差距。这项调查也证实，不同国家和年龄组的认知有差异，凸显了进行有针对性的认识活动的必要性。这些发现旨在帮助医疗保健提供者和政策制定者进行更有效的教育宣传活动，以解决当前 PAD 意识方面的缺陷。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章全球覆膜支架市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 覆膜支架市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 覆膜支架市场：依产品估算与趋势分析

  • 覆膜支架市场：依产品分类的仪表板
  • 覆膜支架市场：产品变化分析
  • 2018-2030 年覆膜支架市场规模、预测与趋势分析（按产品）
  • 血管支架
  • 非血管支架

第五章 覆膜支架市场：依最终用途分类的估算与趋势分析

  • 覆膜支架市场：依最终用途分類的仪表板
  • 覆膜支架市场：最终用途变化分析
  • 2018-2030 年覆膜支架市场规模、预测与趋势分析（依最终用途）
  • 医院
  • 门诊护理中心 (ACS)
  • 专科诊所

第六章 覆膜支架市场：依国家、产品和最终用途进行的区域估计和趋势分析

  • 全球覆膜支架市场：区域仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co. KG
    • WL Gore &Associates, Inc.
    • Cook
    • Terumo Corporation
    • B. Braun Interventional Systems, Inc.
    • BD
    • Getinge
Product Code: GVR-4-68040-421-3

Covered Stent Market Size & Trends:

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. The market's growth is driven by the increasing prevalence of vascular diseases, advancements in covered stent technology, greater awareness and diagnosis, and the expanding range of applications and indications. In April 2024, the American Heart Association, Inc. reported that the global prevalence of lower extremity peripheral artery disease (PAD), affecting between 116 and 230 million people, is a major factor driving the increased demand for covered stents. This high prevalence underscores the urgent need for effective vascular interventions, positioning covered stents as a critical solution for managing PAD and enhancing patient care worldwide.

Technological advancements in covered stents are propelling the market growth. A February 2023 article by MDPI highlights that covered stents are now being designed with advanced biocompatible polymers, such as polytetrafluoroethylene (PTFE). These materials serve as barriers to prevent tissue ingrowth, significantly reducing the risk of restenosis. Additionally, they are particularly effective in sealing off exposed inflammatory surfaces, which may help inhibit the development of neointimal hyperplasia.

Moreover, in November 2023, 3D printing technology is revolutionizing the creation of personalized covered stents tailored to match the unique anatomical structures of individual patients. This approach allows the production of stents with customized dimensions and mechanical properties, improving their performance and integration within the vascular system. Furthermore, the latest generations of covered stents incorporate drug-eluting capabilities, enabling localized delivery of anti-proliferative drugs to mitigate the risk of restenosis further. Ongoing research is exploring the sequential release of multiple drugs to optimize healing processes and minimize complications.

The superior efficacy of covered stents is a key driver of market growth. An article published by Elsevier Ltd. in April 2024 highlights the advantages of covered stents over bare-metal stents in treating chronic mesenteric ischemia. A study conducted across six centers in the Netherlands found that covered stents had significantly better long-term patency, with 81% maintaining primary patency at 24 months, compared to just 49% for bare-metal stents. This enhanced performance underscores the increasing preference for covered stents, fueling their adoption in vascular procedures.

Increased awareness and diagnosis are key factors driving market growth. According to a Yale School of Medicine article published in September 2023, September has been designated as National Peripheral Artery Disease (PAD) Awareness Month. This initiative aims to raise public awareness about PAD by educating people on its risk factors, symptoms, and the importance of early diagnosis. Throughout the month, various organizations conduct outreach efforts, provide educational materials, and encourage at-risk individuals to undergo vascular screenings. The primary goal is to emphasize the importance of early detection and treatment to prevent serious complications associated with PAD.

Additionally, international surveys conducted in March 2021 assessed public awareness of PAD in various countries, revealing that 57% of participants were unfamiliar with the condition, highlighting a significant knowledge gap. The surveys also identified variations in awareness between countries and across age groups, underscoring the need for targeted awareness initiatives. These findings aim to assist healthcare providers and policymakers in developing more effective educational campaigns to address the current shortcomings in PAD awareness.

Global Covered Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global covered stent market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Vascular Stent
  • Non-vascular Stent
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Care Centers (ACS)
  • Specialty Clinics
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Covered Stent Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of vascular diseases
      • 3.2.1.2. Technological advancements in covered stent
      • 3.2.1.3. Increased awareness and diagnosis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of covered stents
      • 3.2.2.2. Regulatory compliance
  • 3.3. Covered Stent Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Covered Stent Market: Product Estimates & Trend Analysis

  • 4.1. Covered Stent Market: Product Dashboard
  • 4.2. Covered Stent Market: Product Movement Analysis
  • 4.3. Covered Stent Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Vascular Stent
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Non-vascular Stent
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Covered Stent Market: End Use Estimates & Trend Analysis

  • 5.1. Covered Stent Market: End Use Dashboard
  • 5.2. Covered Stent Market: End Use Movement Analysis
  • 5.3. Covered Stent Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Ambulatory Care Centers (ACS)
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Specialty Clinics
    • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Covered Stent Market: Regional Estimates & Trend Analysis by Country, Product, & End Use

  • 6.1. Global Covered Stent Market: Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Regulatory framework/ reimbursement structure
      • 6.3.4.3. Competitive scenario
      • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Denmark
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Regulatory framework/ reimbursement structure
      • 6.4.9.3. Competitive scenario
      • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.3. South Africa
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Boston Scientific Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Medtronic
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Biotronik SE & Co. KG
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. W. L. Gore & Associates, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Cook
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Terumo Corporation
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. B. Braun Interventional Systems, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BD
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Getinge
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global covered stent market by end use, 2018 - 2030
  • Table 5 Global Covered Stent market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 7 North America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 8 North America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 9 U.S covered stent market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S covered stent market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada covered stent market by product, 2018 - 2030 (USD Million)
  • Table 12 Canada covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 13 Mexico covered stent market by product, 2018 - 2030 (USD Million)
  • Table 14 Mexico covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe covered stent market by country, 2018 - 2030 (USD Million)
  • Table 16 Europe covered stent market by product, 2018 - 2030 (USD Million)
  • Table 17 Europe covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 18 UK covered stent market by product, 2018 - 2030 (USD Million)
  • Table 19 UK covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany covered stent market by product, 2018 - 2030 (USD Million)
  • Table 21 Germany covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 22 France covered stent market by product, 2018 - 2030 (USD Million)
  • Table 23 France covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 24 Italy covered stent market by product, 2018 - 2030 (USD Million)
  • Table 25 Italy covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 26 Spain covered stent market by product, 2018 - 2030 (USD Million)
  • Table 27 Spain covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 28 Denmark covered stent market by product, 2018 - 2030 (USD Million)
  • Table 29 Denmark covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 30 Sweden covered stent market by product, 2018 - 2030 (USD Million)
  • Table 31 Sweden covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 32 Norway covered stent market by product, 2018 - 2030 (USD Million)
  • Table 33 Norway covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific covered stent market by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific covered stent market by product, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan covered stent market by product, 2018 - 2030 (USD Million)
  • Table 38 Japan covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 39 China covered stent market by product, 2018 - 2030 (USD Million)
  • Table 40 China covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 41 India covered stent market by product, 2018 - 2030 (USD Million)
  • Table 42 India covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia covered stent market by country, 2018 - 2030 (USD Million)
  • Table 44 Australia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 45 Australia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand covered stent market by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 48 South Korea covered stent market by product, 2018 - 2030 (USD Million)
  • Table 49 South Korea covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 50 Latin America covered stent market by country, 2018 - 2030 (USD Million)
  • Table 51 Latin America covered stent market by product, 2018 - 2030 (USD Million)
  • Table 52 Latin America covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 53 Brazil covered stent market by product, 2018 - 2030 (USD Million)
  • Table 54 Brazil covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 55 Argentina covered stent market by product, 2018 - 2030 (USD Million)
  • Table 56 Argentina covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 57 MEA covered stent market, by country, 2018 - 2030 (USD Million)
  • Table 58 MEA covered stent market by product, 2018 - 2030 (USD Million)
  • Table 59 MEA covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 60 South Africa covered stent market by product, 2018 - 2030 (USD Million)
  • Table 61 South Africa covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia covered stent market by product, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 64 UAE covered stent market by product, 2018 - 2030 (USD Million)
  • Table 65 UAE covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 66 Kuwait covered stent market by product, 2018 - 2030 (USD Million)
  • Table 67 Kuwait covered stent market by end use, 2018 - 2030 (USD Million)
  • Table 68 Participant's overview
  • Table 69 Financial performance
  • Table 70 Key companies undergoing expansions
  • Table 71 Key companies undergoing acquisitions
  • Table 72 Key companies undergoing collaborations
  • Table 73 Key companies launching new products
  • Table 74 Key companies undergoing partnerships
  • Table 75 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Covered stent market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Covered stent market revenues, 2023 (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's Five Forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Covered stent market Product outlook:
  • Fig. 14 Covered stent market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 17 Global non-vascular stent market, 2018 - 2030 (USD Million)
  • Fig. 18 Covered stent market end use outlook:
  • Fig. 19 Covered stent market: end use movement analysis
  • Fig. 20 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory care centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional market place: Key takeaways
  • Fig. 24 North America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S covered stent market, 2018 - 2030 (USD Million)
  • Fig. 26 Canada covered stent market, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico covered stent market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe covered stent market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany covered stent market, 2018 - 2030 (USD Million)
  • Fig. 30 UK covered stent market, 2018 - 2030 (USD Million)
  • Fig. 31 France covered stent market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy covered stent market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain covered stent market, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific covered stent market, 2018 - 2030 (USD Million)
  • Fig. 35 Japan covered stent market, 2018 - 2030 (USD Million)
  • Fig. 36 China covered stent market, 2018 - 2030 (USD Million)
  • Fig. 37 India covered stent market, 2018 - 2030 (USD Million)
  • Fig. 38 Australia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 39 Latin America covered stent market, 2018 - 2030 (USD Million)
  • Fig. 40 Brazil covered stent market, 2018 - 2030 (USD Million)
  • Fig. 41 MEA covered stent market, 2018 - 2030 (USD Million)
  • Fig. 42 South Africa covered stent market, 2018 - 2030 (USD Million)
  • Fig. 43 Saudi Arabia covered stent market, 2018 - 2030 (USD Million)
  • Fig. 44 Market Participant Categorization
  • Fig. 45 Strategy mapping